期刊文献+

乳腺癌脑转移预测模型的研究 被引量:1

The predictive model of brain metastases of breast cancer
原文传递
导出
摘要 目的探讨乳腺癌患者发生脑转移的危险因素和利用Logistic回归模型预测乳腺癌脑转移概率。方法对165例乳腺癌患者的年龄、分期、雌激素受体(ER)、孕激素受体(PR)及人类表皮生长因子受体-2(Her-2)评分、月经状态、是否进行辅助化疗、远处第一转移灶、无转移生存期进行分析,建立乳腺癌脑转移预测模型。结果确诊年龄〈35岁、腋淋巴结转移数≥4个、ER阴性、Her-2阳性是乳腺癌发生脑转移的独立危险因素(P〈0.05)。获得的预测模型的预测能力为0.783±0.037,预测脑转移发生的灵敏度、特异度可分别达0.786和0.765。结论临床可利用该模型预测乳腺癌患者脑转移的概率,且预测概率≥0.75。 Objective To investigate the risk factors of brain metastases of breast cancer and pre- dictive ability of the predictive model of brain metastases in breast cancer. Methods All the 165 breast cancer patients were analyzed for age, stage, estrogen receptor (ER), progesterone receptor (PR), hu- man epidermal growth factor receptor-2 (Her-2) , number of metastasic axillary menstrual status, adjuvant chemotherapy regimen, first sites of metastasis and metastasis-free survival. Results Younger than 35 years old at diagnosis, more than or equal to four metastatic axillary nodes, negative estrogen receptor and postive Herb-2 were independent risk factors associated with brain metastases of breast cancer. The predic- tive ability of the predictive model, which was measured as area under the curve, was 0. 783 ± 0. 037, and the sensitivity and specificity for predicting the occurrence of brain metastases were 0. 786 and 0. 765 re- spectively. Conclusion The predictive model can be used for predicting the occurrence of brain metastases of breast cancer.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第8期1714-1716,共3页 Chinese Journal of Experimental Surgery
关键词 乳腺癌 脑转移 危险因素 预测模型 Breast cancer Brain metastases Risk factor Predictive model
  • 相关文献

参考文献10

  • 1Grewal J,Kesari S.Breast cancer surface receptors predict risk fordeveloping brain metastasis and subsequent prognosis.Breast CancerRes,2008,10:104.
  • 2Tham YL,Sexton K,Kramer R,et al.Primary breast cancer pheno-types associated with propensity for central nervous system metasta-ses.Cancer Am Cancer Soc,2006,107:690-704.
  • 3Siegel R,DeSantis C,Virgo K,et al.Cancer treatment and survivor-ship statistics.CA Cancer J Clin,2012,62:220-241.
  • 4Siegel R,Naishadham D,Jemal A.Cancer statistics,2012.CA Canc-er J Clin,2012,62:10-29.
  • 5Eccles SA,Paon L.Breast cancer metastasis:when,where,how?.Lancet,2005,365:1006-1007.
  • 6王深明,马浙夫.乳腺癌临床和实验研究的新进展[J].中华实验外科杂志,2012,29(5):786-789. 被引量:21
  • 7Shaffrey ME,Mut M,Asher AL,et al.Brain metastases.Curr ProblSurg,2004,41:665-741.
  • 8Souglakos J,Yamvakas L,Apostolaki S,et al.Central nervous systemrelapse in patients with breast cancer is associated with advanced sta-ges,with the presence of circulating occult tumor cells and with theHER2/neu status.Breast Cancer Res,2006,8:R36.
  • 9Pharoah PD,Antoniou AC,Easton DF,et al.Polygenes,risk predic-tion,and targeted prevention of breast cancer.N Engl J Med,2008,358:2796-2803.
  • 10刘子瑜,牛昀,刘宁,张静,吕淑华,丁秀敏.乳腺乳头状癌的临床病理特征和分子免疫表型[J].中华实验外科杂志,2012,29(5):821-823. 被引量:1

二级参考文献49

  • 1王晓稼,郑树,彭佳萍,吴金民.乳腺癌患者ST13、Hsp70、pS2、雌激素受体和孕激素受体表达及其与生存的关系[J].中华实验外科杂志,2005,22(9):1071-1073. 被引量:7
  • 2Siegel R, Naishadham D ,Jemal A. Cancer statistics ,2012. CA Cancer J Clin ,2012,62 : 10-29.
  • 3Bittner JJ. Some possible effects of nursing on the mammary gland tumor incidence in mice. Science, 1936,84 : 162.
  • 4Yarden RI, Friedman E, Metsuyanim S, et al. Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent. Mol Carcinog, 2010,49:545-555.
  • 5Peshkin BN, Alabek ML, Isaacs C. BRCA1/2 mutations and triple negative breast cancers. Breast Dis,2011,32:25-33.
  • 6Manoukian S, Peissel B, Frigerio S, et al. Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations. Breast Cancer Res Treat, 2011,130:207-215.
  • 7Ma Z, Gibson SL, Byme MA, et al. Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis. Mol Cell Biol, 2006,26:9338 -9351.
  • 8Nagle JA, Ma z, Byrne MA, et al. Involvement of insulin receptor substrate 2 in mammary tumor metastasis. Mol Cell Biol, 2004,24 : 9726-9735.
  • 9Gibson SL,Ma Z, Shaw LM. Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis. Cell Cycle, 2007,6:631-637.
  • 10Stavik B, Skretting G, Aasheim HC, et al. Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility. BMC Cancer, 2011,11:357.

共引文献20

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部